| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $337,904 ) |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI131703 | Regulation of T cell memory in tissue immunity | 000 | 7 | NIH | 11/26/2025 | $555,000 |
| | 2026 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01AI144616 | DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity | 000 | 7 | NIH | 11/26/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA195547 | The St. Jude Lifetime Cohort | 000 | 10 | NIH | 11/21/2025 | -$1,085 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99CA283256 | Functional and Pharmacologic Investigation of the NUP98 Fusion Oncoprotein Interactome | 000 | 2 | NIH | 11/17/2025 | $0 |
| | 2026 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA193651 | Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias | 000 | 11 | NIH | 11/18/2025 | $0 |
| | 2026 | 2023 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA261713 | PreDM: An adaptive, open-label, pilot intervention trial for diabetes prevention | 000 | 2 | NIH | 11/19/2025 | $0 |
| | 2026 | 2022 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA193478 | Web-based Physical Activity Intervention for Children with ALL | 000 | 6 | NIH | 11/20/2025 | $0 |
| | 2026 | 2020 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA246510 | Sen-Survivors: An open-label intervention trial for frailty and senescence | 000 | 1 | NIH | 10/1/2025 | -$3,834 |
| | 2026 | 2020 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EB028338 | Novel imaging agents of oxidative stress in the pathophysiology of the central nervous system | 001 | 2 | NIH | 10/1/2025 | -$12,458 |
| | 2026 | 2020 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EB028338 | Novel imaging agents of oxidative stress in the pathophysiology of the central nervous system | 000 | 2 | NIH | 10/1/2025 | -$199,718 |
|
| Issue Date FY: 2025 ( Subtotal = $123,968,647 ) (Continued on the next page) |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01DK140461 | Extracellular matrix in vertebrate hematopoietic stem cell specification | 000 | 2 | NIH | 6/24/2025 | $370,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG075869 | REGULATION OF PROTEOSTASIS AND TAUOPATHY BY MALTOSE-INDUCED SIGNALING | 001 | 2 | NIH | 8/4/2025 | $37,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG075869 | REGULATION OF PROTEOSTASIS AND TAUOPATHY BY MALTOSE-INDUCED SIGNALING | 000 | 2 | NIH | 1/23/2025 | $416,250 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21AI178085 | Trivalent Live Attenuated Vaccines for Bacterial Acute Otitis Media | 000 | 2 | NIH | 12/9/2024 | $220,675 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA289881 | Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity | 000 | 1 | NIH | 1/10/2025 | $718,113 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA280187 | Caregiver Education with Interactive Neurodevelopmental Games to Improve Cognitive and Social-Emotional Outcomes in Infants Undergoing Treatment for Medulloblastoma | 000 | 2 | NIH | 6/12/2025 | $217,600 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA263969 | In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas | 001 | 5 | NIH | 7/7/2025 | $767,363 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY037117 | The Role of Müller Glia in Acute and Chronic Response to Stress, Injury, and Disease in the Retina | 000 | 1 | NIH | 1/15/2025 | $606,034 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM155423 | Chemical approaches for targeting ribonucleoprotein assemblies | 000 | 2 | NIH | 7/14/2025 | $462,500 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA290805 | Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy | 000 | 1 | NIH | 12/30/2024 | $738,024 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM157243 | Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics | 000 | 1 | NIH | 12/24/2024 | $462,500 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32HL176447 | Basic and Translational Research Training in Pediatric Classical Hematology | 001 | 1 | NIH | 9/6/2025 | -$2,034 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32HL176447 | Basic and Translational Research Training in Pediatric Classical Hematology | 000 | 1 | NIH | 12/26/2024 | $252,285 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01DC021511 | Sensory-evoked adenosine release in cortical plasticity | 000 | 2 | NIH | 5/6/2025 | $561,784 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121114 | Understanding the sequence and structural determinants of phase behavior of ALS-causing proteins | 000 | 5 | NIH | 2/20/2025 | $561,572 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121114 | Understanding the sequence and structural determinants of phase behavior of ALS-causing proteins | 001 | 5 | NIH | 8/5/2025 | $62,397 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99DK134844 | Hematopoietic stem cell defects in Diamond-Blackfan Anemia | 000 | 2 | NIH | 4/8/2025 | $90,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA255569 | WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor | 000 | 5 | NIH | 12/12/2024 | $194,741 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI170765 | Targeting NuoD for the treatment of H. pylori | 000 | 3 | NIH | 4/15/2025 | $844,980 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R00AI159295 | Cis-interaction mediated CD28 costimulation | 000 | 4 | NIH | 8/18/2025 | $249,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI168214 | Consequences of Direct Viral-Bacterial Interactions | 000 | 4 | NIH | 12/9/2024 | $487,212 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH136215 | Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | 001 | 1 | NIH | 11/29/2024 | $9,436 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH136215 | Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | 000 | 1 | NIH | 11/27/2024 | $721,599 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS139519 | Polarity Signals Coordinate Neuronal Differentiation & Nuclear Organization | 000 | 1 | NIH | 11/22/2024 | $676,388 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI131703 | Regulation of T cell memory in tissue immunity | 000 | 6 | NIH | 11/13/2024 | $538,352 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI187465 | Epigenetic Checkpoint Regulation of Naive T-cell Quiescence and Peripheral Tolerance | 000 | 1 | NIH | 7/22/2025 | $3,428,212 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122462 | Structure and functional mechanisms of molecular chaperones and protein kinases | 002 | 9 | NIH | 8/5/2025 | $76,430 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122462 | Structure and functional mechanisms of molecular chaperones and protein kinases | 001 | 9 | NIH | 2/24/2025 | $687,854 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01AI144616 | DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity | 002 | 7 | NIH | 8/21/2025 | $4,797,577 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25GM150178 | Memphis STEM-M Ambassadors | 000 | 3 | NIH | 8/20/2025 | $255,223 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25GM150178 | Memphis STEM-M Ambassadors | 001 | 3 | NIH | 9/16/2025 | $0 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM144566 | Structural Basis of Programmable DNA-Insertion via Cryo-EM Studies of CRISPR-Associated TnsC | 004 | 4 | NIH | 8/7/2025 | $38,219 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM144566 | Structural Basis of Programmable DNA-Insertion via Cryo-EM Studies of CRISPR-Associated TnsC | 003 | 4 | NIH | 12/9/2024 | $343,981 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35CA253096 | Identifying the mechanisms of leukemia progression | 000 | 5 | NIH | 8/22/2025 | $1,077,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY036689 | The Role of Modular Super-Enhancers in the Developing Murine and Human Retina | 000 | 2 | NIH | 3/31/2025 | $596,514 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA294103 | Discovering the mechanisms underlying oncogenesis by ZFTA-RELA and pinpointing therapeutic targets. | 000 | 2 | NIH | 8/14/2025 | $601,250 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01AI176471 | Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs | 000 | 3 | NIH | 4/16/2025 | $479,100 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA281823 | Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma | 000 | 3 | NIH | 9/5/2025 | $498,337 |
|
